83
52
Growth Score 83 in past quarter
-5 pts
Heat Score 52 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
489302
iTind is committed to improve the quality of life in the male population by commercializing an office based procedure for BPH.
- Ido Kilemnik: Founder & CEO

Olympus
About the Company
iTind is an Israeli medical device company. Our company is dedicated to improving men’s healthcare and quality of life via effective, non-surgical solutions for Benign Prostatic Hyperplasia (BPH). The flagship iTind treatment for BPH currently has the EU CE Mark and is approved for sale in the European Union, UK, Israel, Australia, Brazil, and FDA
cleared for use in the USA.
